Revia and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Revia (naltrexone hydrochloride), especially for people who are male, 50-59 old, also take Neurontin, and have Depression.

The phase IV clinical study analyzes which people have Overdose when taking Revia. It is created by eHealthMe based on reports of 504 people who have side effects when taking Revia from the FDA, and is updated regularly.

What is Revia?

Revia has active ingredients of naltrexone hydrochloride. It is often used in alcoholism. eHealthMe is studying from 555 Revia users. Check the latest studies of Revia.

What is Overdose?

Overdose is found to be associated with 2,219 drugs and 2,471 conditions by eHealthMe. Check the latest studies of Overdose.

On Jul, 10, 2026

504 people reported to have side effects when taking Revia.
Among them, 14 people (2.78%) have Overdose.

Among these 14 people:

What is the gender of people who have Overdose when taking Revia? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Overdose when taking Revia? *

What are other drugs people take besides Revia? *

What are other side effects people have besides Overdose? *

Suicide Attempt: 6 people, 42.86%
Pain: 5 people, 35.71%
Gun Shot Wound: 4 people, 28.57%
Depression: 4 people, 28.57%
Stress And Anxiety: 3 people, 21.43%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 21.43%
Respiratory Depression (respiration has a rate below 12 breaths): 3 people, 21.43%
Scar: 3 people, 21.43%
Migraine (headache): 3 people, 21.43%
Irritability: 3 people, 21.43%

What are the existing conditions these people have? *

Depression: 3 people, 21.43%
Mood Swings (an extreme or rapid change in mood): 2 people, 14.29%
Bipolar Disorder (mood disorder): 2 people, 14.29%
Post-Traumatic Stress Disorder: 1 person, 7.14%
Alcohol Withdrawal Syndrome: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Revia and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revia:

Revia (555 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Revia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,219 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,471 conditions)

Related publications that referenced our studies

Behnoush B, Memarian A, Teimoory M, "Naltrexone Induced Serotonin Syndrome", International Journal of Medical Toxicology and Forensic Medicine, 2013 Apr .
Behnoush B, Memarian A, Teimoory M, "Naltrexone Induced Serotonin Syndrome", International Journal of Medical Toxicology and Forensic Medicine, 2013 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on naltrexone hydrochloride (the active ingredients of Revia) and Revia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.